Sun Pharmaceutical Industries is expected to release its Q2 earnings on October 28. Analysts predict a net profit of around Rs 2,911 crore for the July-September quarter, which would be a 22.5% increase compared to the same period last year.
Revenue is also expected to rise by over 9% to Rs 13,299 crore. A Moneycontrol poll of ten brokerages shows a range of earnings forecasts, with the most optimistic estimate suggesting a 38% surge in net profit and the most conservative projection indicating an 11.5% increase.
However, higher research and development expenses aimed at improving the specialty segment may limit margin growth for the company.